Chronic kidney disease: assessment and management

Supporting evidence

• Surveillance report

• November 2023 exceptional surveillance of blood pressure targets for adults across NICE guidelines (NICE guidelines NG17, NG136 and NG203)

• 2021 exceptional surveillance of HIV indicator conditions (NICE guidelines NG52, CG153, NG122 and NG203)

• 2021 exceptional surveillance of chronic kidney disease (NICE guideline NG203)

• Full guidance

• Full guideline – 2015 (Anaemia management in CKD) (PDF 4.33 MB)

  Published:

  25 August 2021

• Full guideline – 2014 (Early identification and management of CKD in adults in primary and secondary care) (PDF 9.29 MB)

  Published:

  25 August 2021

• Full guideline – 2014 (Early identification and management of CKD in adults in primary and secondary care: appendices A to R) (PDF 13.43 MB)

  Published:

  25 August 2021

• Full guideline – 2013 (Hyperphosphataemia in CKD) (PDF 1.6 MB)

  Published:

  25 August 2021

• Evidence review

• Evidence reviews – August 2021

• A: Diagnostic accuracy of eGFR calculations in adults, children, and young people from black, Asian and other minority ethnic groups with CKD (PDF 1.5 MB)

  Published:

  25 August 2021

• B: Accuracy of albumin: creatinine ratio versus protein creatinine ratio measurements to quantify proteinuria in children and young people with CKD (PDF 919 KB)

  Published:

  25 August 2021

• C: Accuracy of reagent strips for detecting protein and blood in urine in children and young people with CKD (PDF 926 KB)

  Published:

  25 August 2021

• D: Children and young people who should be tested for CKD (PDF 922 KB)

  Published:

  25 August 2021

• E: Optimal monitoring frequency (PDF 1.09 MB)

  Published:

  25 August 2021

• F: The best combination of measures to identify increased risk of progression in adults, children and young people (PDF 3.73 MB)

  Published:

  25 August 2021

• G: Optimal blood pressure targets for adults, children and young people with CKD (PDF 2.2 MB)

  Published:

  25 August 2021

• H: Interventions to lower proteinuria (PDF 4.02 MB)

  Published:

  25 August 2021

• I: eGFR threshold for the investigation of anaemia due to chronic kidney disease (PDF 1.83 MB)

  Published:

  25 August 2021

• J: Aspirational haemoglobin target range for children and young people with CKD (PDF 972 KB)

  Published:

  25 August 2021

• K: Managing anaemia with IV iron in people with GFR category G5 who are on dialysis (PDF 2.33 MB)

  Published:

  25 August 2021

• L: Use of phosphate binders (PDF 18.83 MB)

  Published:

  25 August 2021

• M: Cystatin C based equations to estimate GFR in adults, children and young people (PDF 1.39 MB)

  Published:

  25 August 2021

• N: Defining clinically significant decline in eGFR in terms of risk of kidney disease progression (PDF 4.39 MB)

  Published:

  25 August 2021